4Shratori Y, Tannaka M, Umihara J, et al. Leukotriene inhibitors moelulate hepatic injury induced by lipopolysaccharide - activated macrophages. J Hepatology, 1990,10:51-61.
5Laskin DL. Noparenchymal cells and hepatotoxcity. Semin Liver Dis, 1990,10:293-304.
6Billiar TR, Curran RD, Williams DL, et al. Liver noparenchymal cells stimulated to provide interleukin-6 for incluction of the hepatic acute phase response in endotoxemia but not in remote localized in flammation. Arch Surg, 1992,127:31-36.
7Sharabi Y, Eldad A. Nonalcoholic fatty liver disease is association with hypolipidemia and obesity. Am J Med,2000,109:117.
8Stadler J, Bebntz BG, Harbrecht BG, et al. Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration. Ann Surg, 1992,216:539-546.
10Matteoni CA, Younossi ZM, Gramilch T, et al. Nonalcoholic fatty liver disease:A spectrum of clinic and pathology severity. Gastroenterology, 1999,116:1413-1419.
7Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. Ⅱ. Cytochrome P450 enzymes and oxidative stress [J]. Am J Physiol Gastrointest Liver Physiol, 2001,281 ( 5 ) : G1135-G1139.
8Sanyal A J, Campbell-Sargent C, Mirshahi F. Nonalcoholic steatohepatitis : association of insulin resistance and mitochondrial ahnormalities [ J ]. Gastroenterology ,2001,120 ( 5 ) : 1183-1192.
9Rouach H, Fataccioli V, Gentil M, et al. Effect of chronic ethanol feeding on hipid peroxidation and protein oxidation in relation to liver pathology[ J ]. Hepatology, 1997,25 (2) :351-355.
10Uchino S, Yamaguchi Y, Furuhashi T, et al. Steatotic liverallografts up-regulate UCP-2 expression and suffer necrosis inrats [ J ]. J Surg Res ,2004,120( 1 ) :73-82.
